Pharmacological properties of nifedipine are compared to those of othe
r calcium antagonists. The author disagrees with those investigators w
ho make conclusions on nifedipine inadequacy in any forms of ischemic
heart disease emphasizing its negative effect on the survival. The aut
hor argues that negative effects of nifedipine are proved in unstable
angina pectoris and acute myocardial infarction whereas in stable angi
na of effort its effectiveness may be superior to other antianginal dr
ugs. Such unwanted events as developing tolerance to nifedipine in its
long-term use, withdrawal syndrome in its sudden discontinuation are
not unevitable. It is thought valid to prescribe nifedipine in stable
ischemic heart disease.